Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

NCT01312350 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hypopharyngeal Cancer

Interventions

DRUG: neoadjuvant docetaxel/cisplatin/fluorouracil
DRUG: No treatment before definitive CCRT

Sponsor

Samsung Medical Center